Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01652235 · ClinicalTrials.gov registry record · NA

Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study

A NA study, sponsored by Cook Research Incorporated.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT01652235 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01652235, a NA study, has completed, sponsored by Cook Research Incorporated.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Single-Center Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic aneurysms.

Interventions

  • DEVICE Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2008-07
Est. Completion 2023-09-26
Phase NA

Sponsor

Cook Research Incorporated

24 total trials

What the Registry Record Tells You About NCT01652235

The ClinicalTrials.gov registry entry for NCT01652235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft is the first listed.

NCT01652235 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01652235 about?

NCT01652235 is a clinical study titled "Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study". The Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Single-Center Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic aneurysms.

What is the current status of trial NCT01652235?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2008-07. Estimated completion is 2023-09-26.

What interventions are being tested in trial NCT01652235?

The interventions under investigation include: Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft (DEVICE).

Who is sponsoring clinical trial NCT01652235?

This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.